3 Pharma Stocks to Watch: Allergan, Valeant, and AbbVie
3 Pharma Stocks to Watch: Allergan, Valeant, and AbbVie Motley Fool
View ArticleAllergan reiterates belief that Valeant model unsustainable in new presentation
Allergan reiterates belief that Valeant model unsustainable in new presentation Yahoo/Fly on the Wall
View ArticleAckman urges Allergan talks with Valeant, no delay to special meeting
Ackman urges Allergan talks with Valeant, no delay to special meeting Yahoo/Reuters
View Article3 Stocks Advancing The Drugs Industry
3 Stocks Advancing The Drugs Industry TheStreet.com
View ArticleJohn Paulson: Allergan can't continue alone
John Paulson: Allergan can't continue alone Marketwatch
View ArticlePaulson says Allergan could be wroth $220 per share, WSJ reports
Paulson says Allergan could be wroth $220 per share, WSJ reports Yahoo/Fly on the Wall
View ArticleAckman to Allergan shareholders: Valeant's offer won't last forever
Ackman to Allergan shareholders: Valeant's offer won't last forever Fierce Pharma
View ArticleDrugmaker Valeant touts Bausch + Lomb growth to Allergan investors
Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors Yahoo/Reuters
View ArticleAlzheimer's Needs Cures, Not Pyrrhic Victories
Alzheimer's Needs Cures, Not Pyrrhic Victories Motley Fool
View ArticleAllergan to Cut About 1,500 Jobs in Restructuring
Allergan to Cut About 1,500 Jobs in Restructuring Bloomberg
View ArticleValeant accuses Allergan of making misleading statements
Valeant accuses Allergan of making misleading statements Marketwatch
View ArticleHow Much Will Those Allergan Cost Cuts Really Help? Read Here
How Much Will Those Allergan Cost Cuts Really Help? Read Here WSJ Online
View ArticleAllergan stand alone value now above Valeant offer, says Bernstein
Allergan stand alone value now above Valeant offer, says Bernstein The Fly on the Wall
View ArticleAllergan Reiterates Plan to Preempt Valeant Offer
Allergan Reiterates Plan to Preempt Valeant Offer TheStreet.com
View ArticleOminous Signs For Valeant In The Allergan Q2 Earnings Call
Ominous Signs For Valeant In The Allergan Q2 Earnings Call Seeking Alpha
View ArticleValeant files official complaint about Allergan with Canadian regulator
Valeant files official complaint about Allergan with Canadian regulator Marketwatch
View ArticleIf Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds
If Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds WSJ Online
View ArticleWall Street Junk Euphoria Backs Ackman’s Allergan Dreams
Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams Bloomberg
View ArticleAs legislator rails on potential Valeant-Allergan deal, Wall Street lines up...
As legislator rails on potential Valeant-Allergan deal, Wall Street lines up to fund it Fierce Pharma
View Article[video] Allergan's Largest Shareholder Sells Most of Holdings
[video] Allergan's Largest Shareholder Sells Most of Holdings Marketwatch/WSJ Online
View Article